Effect of intensive blood-pressure treatment on patient-reported outcomes

New England Journal of Medicine

Volumn 377, Issue 8, 2017, Pages 733-744

  Berlowitz, Dan R ^a,b   Foy, Capri G ^d   Kazis, Lewis E ^a,b   Bolin, Linda P ^d   Conroy, Molly B ^f   Fitzpatrick, Peter ^g   Gure, Tanya R ^h   Kimmel, Paul L ⁱ   Kirchner, Kent ^a   Morisky, Donald E ^k   Newman, Jill ^d   Olney, Christine ^a   Oparil, Suzanne ^l   Pajewski, Nicholas M ^d   Powell, James ^e   Ramsey, Thomas ^l   Simmons, Debra L ^m   Snyder, Joni ^j   Supiano, Mark A ^m,n   Weiner, Daniel E ^c   Whittle, Jeff ^o   more..

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY   (United States)

^c TUFTS MEDICAL CENTER   (United States)

^d EAST CAROLINA UNIVERSITY   (United States)

^e EAST CAROLINA UNIVERSITY   (United States)

^f UNIVERSITY OF PITTSBURGH   (United States)

^g MAYO CLINIC   (United States)

^h THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

ⁱ NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^j NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^k UNIVERSITY OF CALIFORNIA   (United States)

^l UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^m UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

ⁿ Education and Clinical Center   (United States)

^o CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; COGNITION; CONTROLLED STUDY; DRUG EFFECT; FOLLOW UP; HUMAN; HYPERTENSION; INTENSIVE CARE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PATIENT HEALTH QUESTIONNAIRE 9; PATIENT SATISFACTION; PATIENT-REPORTED OUTCOME; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CLINICAL TRIAL; COMBINATION DRUG THERAPY; COMPARATIVE STUDY; COMPLICATION; DRUG EFFECTS; FEMALE; HEALTH STATUS; MALE; MEDICATION COMPLIANCE; MIDDLE AGED;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; DRUG THERAPY, COMBINATION; FEMALE; HEALTH STATUS; HUMANS; HYPERTENSION; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PATIENT OUTCOME ASSESSMENT; PATIENT REPORTED OUTCOME MEASURES; PATIENT SATISFACTION;

EID: 85028298407     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1611179     Document Type: Article

References (34)

1. The SPRINT Research Group. A randomized trial of intensive versus standard blood pressure control. N Engl J Med 2015; 373: 2103-16.
2. Ortiz E, James PA. Let's not SPRINT to judgment about new blood pressure goals. Ann Intern Med 2016; 165: 889-90.
3. Saper CB. How low can you go? Ann Neurol 2015; 78: 665-6.
4. Schiffrin EL, Calhoun DA, Flack JM. SPRINT proves that lower is better for nondiabetic high-risk patients, but at a price. Am J Hypertens 2016; 29: 2-4.
5. Moonen JEF, Foster-Dingley JC, de Ruijter W, et al. Effect of discontinuation of antihypertensive treatment in elderly people on cognitive functioning -The DANTE Study Leiden. JAMA Intern Med 2015; 175: 1622-30.
6. Hildrum B, Mykletun A, Stordal E, Bjelland I, Dahl AA, Holmen J. Association of low blood pressure with anxiety and depression: The Nord-Trondelag Health Study. J Epidemiol Community Health 2007; 61: 53-8.
7. Croog SH, Levine S, Testa MA, et al. The effects of antihypertensive therapy on the quality of life. N Engl J Med 1986; 314: 1657-64.
8. Ambrosius WT, Sink KM, Foy CG, et al. The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: The Systolic Blood Pressure Intervention Trial (SPRINT). Clin Trials 2014; 11: 532-46.
9. Selim AJ, Rogers W, Fleishman JA, et al. Updated U.S. population standard for the Veterans RAND 12-item Health Survey (VR-12). Qual Life Res 2009; 18: 43-52.
10. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001; 16: 606-13.
11. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich) 2008; 10: 348-54.
12. Munter P, Joyce C, Holt E, et al. Defining the minimal detectable change in scores on the eight-item Morisky Medication Adherence Scale. Ann Pharmacother 2011; 45(5): 569-75.
13. Selim AJ, Fincke G, Ren XS, et al. Comorbidity assessments based on patient report: Results from the Veterans Health Study. J Ambul Care Manage 2004; 27: 281- 95.
14. Nasreddine ZS, Phillips NA, Bedirian V, et al. The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005; 53: 695-9.
15. Kenny RA, Coen RF, Frewen J, Donoghue OA, Cronin H, Savva GM. Normative values of cognitive and physical function in older adults: findings from the Irish Longitudinal Study on Ageing. J Am Geriatr Soc 2013; 61: Suppl 2: S279-S290.
16. Pajewski NM, Williamson JD, Applegate WB, et al. Characterizing frailty status in the Systolic Blood Pressure Intervention Trial. J Gerontol A Biol Sci Med Sci 2016; 71: 649-55.
17. R Development Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing, 2015 https://www.R-project.org/).
18. Selim AJ, Berlowitz D, Kazis LE, et al. Comparison of health outcomes for male seniors in the Veterans Health Administration and Medicare Advantage plans. Health Serv Res 2010; 45: 376-96.
19. Ware JE Jr, Bayliss MS, Rogers WH, Kosinski M, Tarlov AR. Differences in 4-year health outcomes for elderly and poor, chronically ill patients treated in HMO and fee-for-service systems: Results from the Medical Outcomes Study. JAMA 1996; 276: 1039-47.
20. Lowe B, Unutzer J, Callahan CM, Perkins AJ, Kroenke K. Monitoring depression treatment outcomes with the Patient Health Questionnaire-9. Med Care 2004; 42: 1194-201.
21. Tryambake D, He J, Firbank MJ, O'Brien JT, Blamire AM, Ford GA. Intensive blood pressure lowering increases cerebral blood flow in older subjects with hypertension. Hypertension 2013; 61: 1309- 15.
22. Gangavati A, Hajjar I, Quach L, et al. Hypertension, orthostatic hypotension, and the risk of falls in a community-dwelling elderly population: The Maintenance of Balance, Independent Living, Intellect, and Zest in the Elderly of Boston study. J Am Geriatr Soc 2011; 59: 383-9.
23. Lipsitz LA, Habtemariam D, Gagnon M, et al. Reexamining the effect of antihypertensive medications on falls in old age. Hypertension 2015; 66: 183-9.
24. Grimm RH Jr, Grandits GA, Cutler JA, et al. Relationships of quality-of-life measures to long-Term lifestyle and drug treatment in the Treatment of Mild Hypertension Study. Arch Intern Med 1997; 157: 638-48.
25. O'Connor PJ, Narayan KM, Anderson R, et al. Effect of intensive versus standard blood pressure control on depression and health-related quality of life in type 2 diabetes: The ACCORD trial. Diabetes Care 2012; 35: 1479-81.
26. Wright JT Jr, Fine LJ, Lackland DT, Ogedegbe G, Dennison Himmelfarb CR. Evidence supporting a systolic blood pressure goal of less than 150 mm Hg in patients aged 60 years or older: The minority view. Ann Intern Med 2014; 160: 499- 503.
27. Qaseem A, Wilt TJ, Rich R, et al. Pharmacologic treatment of hypertension in adults aged 60 years or older to higher versus lower blood pressure targets: A clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Ann Intern Med 2017; 166: 430-7.
28. Sabayan B, van Vliet P, de Ruijter W, Gussekloo J, de Craen AJ, Westendorp RG. High blood pressure, physical and cognitive function, and risk of stroke in the oldest old: The Leiden 85-plus Study. Stroke 2013; 44: 15-20.
29. Odden MC, Peralta CA, Haan MN, Covinsky KE. Rethinking the association of high blood pressure with mortality in elderly adults: The impact of frailty. Arch Intern Med 2012; 172: 1162-8.
30. Williamson JD, Supiano MA, Applegate WB, et al. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged ≥75 years: A randomized clinical trial. JAMA 2016; 315: 2673-82.
31. Bress AP, Tanner RM, Hess R, Colantonio LD, Shimbo D, Muntner P. Generalizability of SPRINT results to the U.S. adult population. J Am Coll Cardiol 2016; 67: 463-72.
32. Moser M. Hypertension treatment -A success study. J Clin Hypertens (Greenwich) 2006; 8: 312-4.
33. Jaffe MG, Lee GA, Young JD, Sidney S, Go AS. Improved blood pressure control associated with a large-scale hypertension program. JAMA 2013; 310: 699- 705.
34. Chobanian AV. Time to reassess bloodpressure goals. N Engl J Med 2015; 373: 2093-5.